96 results found

Did you know that 5-HT1A receptors play a crucial role in numerous psychiatric and neurological disorders? With nearly one hundred publications on biased agonism in 2020 alone, this field has seen explosive growth in research interest. We now understand that these receptors are deeply involved in several physiological processes and represent an important the...

Severe depression affects about one in six people throughout their lifetimes, making psychedelic assisted therapy an increasingly important area of research. With one person dying by suicide every eleven minutes according to the CDC, the need for effective treatments has never been more urgent. While traditional approaches help many patients, psychedelics fo...

Epilepsy treatment challenges persist despite affecting over 70 million people worldwide. What's even more concerning is that approximately one-third of these individuals—around 23 million people—suffer from drug-resistant epilepsy (DRE), which significantly increases their risk of premature death and injuries. Despite decades of research and numerous epilep...

Did you know psychedelic assisted therapy has shown remarkable results in clinical trials, with two recent studies demonstrating significant decreases in PTSD symptom severity compared to placebo? This groundbreaking approach to mental health treatment is gaining legitimate scientific backing at an unprecedented pace. Despite promising outcomes, particularly...

The science behind serotonin shows without doubt that our brains work through precise chemical balances. Scientists continue to uncover new details about how serotonin works, yet evidence confirms its vital role in our mental well-being. This neurotransmitter's influence touches every aspect of our brain function and daily life - from helping us think flexib...

Anxiety disorders affect over 300 million people worldwide. Psychedelic therapy shows promise as a new treatment option for mental health conditions. Traditional medications help many patients, yet SSRIs fail to work for 60% of people with PTSD. Mental health treatment continues to evolve faster than ever. The FDA's evaluation of MDMA-assisted therapy could ...

Research has found that serotonin syndrome can seriously affect young people under 25 who take common antidepressants. This medical condition develops when medications push serotonin levels too high in the body. The risk becomes more when people mix SSRIs with other serotonin-boosting drugs or supplements like St John’s wort.

Traditional PTSD treatments lead only half of all patients to remission. Mental health professionals have searched for better ways to help patients who still struggle. Psychedelic treatment now offers new hope for people fighting this challenging condition. Our research on psychedelic therapy shows promising results that could revolutionize PTSD treatment. P...

The increasing public and scientific interest in psychedelics has spurred a broader conversation about their potential therapeutic benefits, especially in the fields of mental health and wellness. Substances like psilocybin (found in magic mushrooms), LSD (lysergic acid diethylamide), DMT (dimethyltryptamine), and ayahuasca are being explored for their poten...

Serotonin, often dubbed the "feel-good" neurotransmitter, plays a pivotal role in regulating our mood, emotions, and overall mental well-being. It is a chemical messenger in the brain that influences a wide range of physiological and psychological functions. From mood regulation to sleep, appetite, and even memory, serotonin impacts many aspects of our daily...

In recent years, the emergence of psychedelic company stocks has captivated investors, especially those interested in new and potentially groundbreaking industries. As research into psychedelic substances like psilocybin, MDMA, and LSD expands, psychedelic companies are making strides in the pharmaceutical, mental health, and wellness sectors. This has led t...

BMB-101 is an innovative drug under development by Bright Minds Biosciences, designed to selectively target the 5-HT2C serotonin receptor. By activating this receptor, BMB-101 aims to address a range of neuropsychiatric conditions, including depression, anxiety, and other mood disorders. Its precise mechanism offers a potential breakthrough in treating condi...